Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: J Neurosurg. 2023 Jan 13;139(2):402–413. doi: 10.3171/2022.12.JNS221490

TABLE 2.

Univariate and multivariate Cox hazards analyses examining factors associated with time to LMD diagnosis

Factor Univariate Analysis Multivariate Analysis
HR (95% CI) p Value OR (95% CI) p Value
Age 1.33 (0.39–4.80) 0.65
M, vs F 0.77 (0.40–1.46) 0.42
Minority, vs White non-Hispanic 2.17 (1.21–3.88) 0.01 1.73 (0.91–3.27) 0.09
Cancer type, breast/gynecological/urothelial vs other 2.36 (1.33–4.18) 0.003 1.17 (0.60–2.25) 0.65
Tumor side, rt vs lt 1.20 (0.66–2.16) 0.55
Location, cerebellum/insula/occipital vs other 3.07 (1.72–5.50) 0.0002 3.25 (1.73–6.11) 0.0003
Absence of extracranial disease 1.94 (1.07–3.54) 0.03 2.49 (1.27–4.88) 0.008
Tumor volume 2.61 (0.46–11.93) 0.24
Time from BM diagnosis to surgery 0.96 (0.14–3.75) 0.96
No. of total BMs at surgery 0.94 (0.12–4.70) 0.95
No. of BMs resected at surgery, 2 vs 1 1.95 (0.60–6.29) 0.27
Additional craniotomies 0.99 (0.52–1.92) 0.99
BM hemorrhage 0.73 (0.39–1.35) 0.32
Cystic tumor 0.93 (0.47–1.84) 0.84
Contact w/ cortical surface 1.32 (0.70–2.51) 0.39
Contact w/ ventricle 2.82 (1.53–5.19) 0.0009 2.82 (1.50–5.30) 0.001
GTR vs STR 0.89 (0.45–1.76) 0.74
Prior intracranial RT 1.12 (0.50–2.49) 0.79
Immediate postop focal RT vs WBRT 1.13 (0.48–2.67) 0.78
WBRT prior to LMD diagnosis 1.06 (0.54–2.08) 0.87
CPI Tx before surgery 1.34 (0.48–3.76) 0.58
CPI Tx after surgery 0.71 (0.34–1.46) 0.35
Other targeted Tx before surgery 1.32 (0.72–2.45) 0.37
Other targeted Tx after surgery 1.32 (0.74–2.35) 0.35
Any systemic therapy postop 0.68 (0.36–1.29) 0.24

Boldface type indicates statistical significance.